|
(b)(4).Concomitant medical products: stent: 2.75x8 rx xience alpine; 3.0x15 rx xience alpine.The device was not returned for evaluation.The reported patient effect of thrombosis is listed in the xience alpine everolimus eluting coronary stent system electronic instructions for use, (ifu) as a known patient effects of coronary stenting procedures.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The two additional xience alpine devices are being filed under separate manufacturer report numbers.
|
|
It was reported that on (b)(6) 2016, a 2.75x8 rx xience alpine, a 3.0x15 rx xience alpine, and a 3.0x12 rx xience alpine drug-eluting stent were implanted for treatment of an unspecified coronary vessel.On (b)(6) 2016, the patient was rehospitalized due to other unspecified cardiovascular symptoms, including thrombosis.Medical intervention was performed via angioplasty and stent placement.The final patient outcome is reportedly unknown.No additional information was provided.
|